Risk Factors for Piperacillin/Tazobactam Resistance in Extended-Spectrum Beta-Lactamase (ESBL) Producing Organisms
| Status: | Completed | 
|---|---|
| Conditions: | Infectious Disease | 
| Therapuetic Areas: | Immunology / Infectious Diseases | 
| Healthy: | No | 
| Age Range: | 18 - Any | 
| Updated: | 6/14/2018 | 
| Start Date: | November 2007 | 
| End Date: | June 2017 | 
This research will be conducted to determine whether risk factors exist for
piperacillin/tazobactam resistance in ESBL organisms.
			piperacillin/tazobactam resistance in ESBL organisms.
This is chart review at UPMC. NO human subject interaction will occur.
Inclusion Criteria:
- Clinical information is collected by chart review of "case" and "control" patients.
- A "case A" patient is defined as follows: One or more clinical cultures are positive
for an ESBL producing bacteria and the organism is piperacillin/tazobactam resistant.
- A "case B" patient is defined as follows: One or more clinical cultures are positive
for an ESBL producing bacteria and the organism is piperacillin/tazobactam
susceptible.
- Additionally, 1 control patient in the hospital at the same time as the case patients
will be randomly selected for each case and are not in either case group.
Exclusion Criteria:
- Patients < 18 years of age
We found this trial at
    1
    site
	Click here to add this to my saved trials